Morgan Stanley’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $369K | Buy |
92,902
+35,745
| +63% | +$142K | ﹤0.01% | 5602 |
|
|
2025
Q1 | $399K | Buy |
57,157
+30,601
| +115% | +$214K | ﹤0.01% | 5432 |
|
|
2024
Q4 | $389K | Buy |
26,556
+6,159
| +30% | +$90.2K | ﹤0.01% | 5526 |
|
|
2024
Q3 | $390K | Buy |
20,397
+8,537
| +72% | +$163K | ﹤0.01% | 5516 |
|
|
2024
Q2 | $209K | Buy |
+11,860
| New | +$209K | ﹤0.01% | 5656 |
|